to determine the incidence of anticipatory vomiting ( av ) and postchemotherapy nausea and vomiting ( pcnv ) in women receiving cyclophosphamide , methotrexate , and 5-fu ( cmf ) adjuvant chemotherapy for breast carcinoma , we studied 52 women randomized to two regimens ( standard-dose and low-dose ) of cmf .
C0025677
methotrexate
C0950521
cmf